Abstract
Ribosomal protein L23 is a new target for gene therapy of cancer. It participates in tumor progression by activating p53, inactivating murine double minute 2, regulating the carcinogenic activity of c-Myc, inducing the multi-drug resistance, and affecting the biologic behaviour of tumors. Generally, it′s considered to be a potential prognostic factor in human cancers. Key words: Neoplasms; Genes, p53; Genes, myc; Drug resistance, multiple; Ribosomal protein L23
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
